The Prediction of Preeclampsia/Toxemia in Twin Pregnancy
NCT01255202 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2010-12-07
Summary
The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.
Conditions
- Preeclampsia/Toxemia
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2011-04-30
- Completion
- 2011-12-31
Countries
- Israel
More Related Trials
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
GenerationGemelli: Longitudinal Study for the Evaluation of the Maternal Exposome on the Health of the Newborn and Child
NCT06617650 ·Status: RECRUITING
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
NCT04058405 ·Status: COMPLETED
-
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
NCT05679206 ·Status: RECRUITING
-
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction
NCT02379494 ·Status: COMPLETED
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Obstetric and Neonatal Outcomes of Twin Pregnancy
NCT04588597 ·Status: UNKNOWN
-
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049 ·Status: UNKNOWN
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
NCT02854501 ·Status: COMPLETED
-
Detection and Identification of Preeclampsia Via Volatile Biomarkers
NCT01291342 ·Status: COMPLETED
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Pulmonary Artery Doppler in Preeclamptic Mothers
NCT06755073 ·Status: COMPLETED
-
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
NCT07125599 ·Status: COMPLETED
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study
NCT07299773 ·Status: NOT_YET_RECRUITING
-
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia
NCT03149250 ·Status: UNKNOWN
-
Peripartum Anesthetic Management of Patients With Preeclampsia
NCT05237011 ·Status: UNKNOWN
-
Fetal Renal Artery Doppler in Patients With Preeclampsia
NCT06395974 ·Status: COMPLETED
-
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
NCT01195441 ·Status: COMPLETED
-
Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia
NCT06712550 ·Status: COMPLETED